Lecture Title: NLRP3 inflammasome activation drives neurodegeneration in Alzheimer’s disease
Michael Heneka (MH) studied medicine in Tübingen, Lausanne and London from 1990-1996. He obtained his medical degree at the Institute of Pharmacology for which he received the 1998 Attempto Award of the University of Tübingen. While the main focus of his work is related to dementia and Alzheimers Disease, he has also been working on Amyotrophic Lateral Sclerosis and further neurodegenerative disease. After working as a clinical neurologist at the University of Tübingen, Münster and Bonn, he currently serves as the director of the Luxembourg Centre for Systems Biomedicine (LCSB).